Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.08
2.23
NAV
₹24.32
₹374.34
Fund Started
06 Oct 2020
01 Aug 2005
Fund Size
₹188.90 Cr
₹1307.98 Cr
Exit Load
-
Exit load of 1% if redeemed within 30 days.
1 Year
19.96%
12.14%
3 Year
19.72%
24.39%
5 Year
13.12%
14.10%
Equity
99.78%
95.05%
Cash
0.05%
4.95%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.96% |
Eli Lilly And Co | 6.85% |
Apollo Hospitals Enterprise Ltd. | 5.71% |
Max Healthcare Institute Ltd. | 5.21% |
Divi's Laboratories Ltd. | 5.14% |
Cipla Ltd. | 4.84% |
Dr. Reddy's Laboratories Ltd. | 4.44% |
Johnson & Johnson Ltd. | 4.35% |
Lupin Ltd. | 3.62% |
Laurus Labs Ltd. | 3.48% |
Sun Pharmaceutical Industries Ltd. | 8.54% |
Ajanta Pharma Ltd. | 5.08% |
Divi's Laboratories Ltd. | 4.74% |
Gland Pharma Ltd. | 4.11% |
Caplin Point Laboratories Ltd. | 4.02% |
Lupin Ltd. | 3.77% |
Apollo Hospitals Enterprise Ltd. | 3.52% |
Alkem Laboratories Ltd. | 3.14% |
Dr. Reddy's Laboratories Ltd. | 3.01% |
Max Healthcare Institute Ltd. | 2.98% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
06 Oct 2020
01 Aug 2005
